[Prophylactic nodal radiotherapy in prostate cancer]

Area of Science:

• Oncology
• Radiation Oncology
• Urologic Oncology

Background:

• Lymph node invasion in prostate cancer correlates with clinical stage, Gleason score, and PSA levels.
• Historically, pelvic radiotherapy (RT) was used for >15% risk of lymph node metastasis, but its benefit is debated.
• Surgical lymph node dissection data challenges established risk stratification for nodal involvement.

Purpose of the Study:

• To review the principles of prophylactic lymph node irradiation in prostate cancer.
• To discuss the current relevance and uncertainties surrounding this therapeutic approach.
• To examine prospective trials investigating the role of prophylactic irradiation.

Main Methods:

• Review of existing literature on prostate cancer lymph node metastasis and radiotherapy.
• Analysis of data concerning surgical lymph node dissection and its impact on risk assessment.
• Evaluation of advancements in radiotherapy techniques like image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT).

Main Results:

• Increased prostate radiation dose correlates with improved relapse-free survival.
• IGRT and IMRT reduce toxicity associated with pelvic RT.
• The precise benefit of prophylactic pelvic irradiation for occult lymph node metastasis remains uncertain.

Conclusions:

• The role of prophylactic pelvic irradiation in prostate cancer requires further investigation.
• Advancements in RT techniques may mitigate toxicity, but the indication for nodal irradiation needs clarification.
• Prospective trials are essential to define the optimal management of lymph node involvement in prostate cancer.